178.In countries in whichnew lifr-sustaing drugs cannot be patented,such drugs are sald at widely afforable prices;those same drugs,where patented shield patent-holding manufactures from competitors.These facts show that future access to new life-sustaining drugs can be improved if the practice og granting patents on newly developed life-sustaining drugs were to be aolished everywhere.
Which of the following,if true,most seriously weakens the argument?
(A)In countries in which life-sustaining drugs cannot be patented,their manufacture is nevertheless a profitable enterprise.
(B)Countries that do not currently grant patents on life-sustaining drugs are,for te most part,countries with large population.
(C)In some countries specific processes for the manufacture of pharmaceutical drugs can be patented even in cases in which th edrugs themselves cannot be patented.
(D)Pharceutical companies can afford the research that goes into the development of new drugs only if patents allow them to earn high profits.
(E)Countries that grant patents on life-sustaining drugs almost always ban their importation from countries that do not grant such patents.
这个题目我根本就没看懂,希望哪个学长能帮我解释一下,这道题目最后那句话我觉得比杨老师的难句教程还要难。谢谢了
|